Treatment of allergic rhinitis in Europe and the USA – are we an ocean apart?
Article Sidebar
Main Article Content
Abstract
More than 200 million people all over the world suffer from rhinitis. During the last 30 years in Europe as well as in the USA, allergic rhinitis has become the most common chronic noninfectious inflammatory disease of respiratory tract in adults and children. The uniform guidelines for proceedings in allergic rhinitis have been sought for many years. ARIA document has become an important step towards it. The authors present treatment guidelines for allergic rhinitis developed by European and American scientific societies.
Downloads
Article Details
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Arcimowicz M., Buczyłko K., Duda R. et al.: Polskie Standardy Leczenia Nieżytów Nosa (PoSLeNN). Alergologia Polska 2013: S1.
3. Jurkiewicz D., Rapiejko P.: Fizjologia nosa i zatok przynosowych. W: Niemczyk K., Jurkiewicz D., Składzień J. et al. (red.): Otorynolaryngologia kliniczna. Tom 2. MediPage, Warszawa 2015: 319-324.
4. Meltzer E.O., Bukstein D.A.: The economic impact of allergic rhinitis and current guidelines for treatment. Ann. Allergy Asthma Immunol. 2011, 106(supl. 2): S12-S16.
5. Pawankar R., Canonica G., Holgate S.T., Lockey R.F.: Biała Księga Alergii Światowej Organizacji Alergii 2011-2012. World Allergy Organization 2011.
6. Bousquet J., Khaltaev N., Cruz A.A. et al.: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008, 63(supl. 86): 8-160.
7. Jurkiewicz D., Rapiejko P.: Alergiczny nieżyt nosa. W: Niemczyk K., Jurkiewicz D., Składzień J. et al. (red.): Otorynolaryngologia kliniczna. Tom 2. MediPage, Warszawa 2015, 780-786.
8. Kushnir N.M., Kaliner M.A., Scarupa M.D.: In-Depth Review of Allergic Rhinitis [online: http://www.worldallergy.org/professional/allergic_diseases_center/rhinitis/rhinitis_indepth.php].
9. Calderon M.A., Alves B., Jacobson M. et al.: Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst. Rev. 2007, (1): CD001936.
10. Jutel M., Kowalski M.L., Rogala B. et al.: Swoista immunoterapia alergenowa. W: Kruszewski J., Kowalski M.L. (red.): Standardy w alergologii. Stanowiska Panelów Eksperckich Polskiego Towarzystwa Alergologicznego. Część I. Wydanie 2. Medycyna Praktyczna, Kraków 2010: 151-159.
11. Erekosima N., Suarez-Cuervo C., Ramanathan M. et al.: Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope 2014, 124(3): 616-627.
12. Blaiss M.S.: Allergic rhinitis: direct and indirect costs. Allergy Asthma Proc. 2010, 31: 375-380
13. Seidman M.D., Gurgel R.K., Lin S.Y. et al.: Clinical Practice Guideline: Allergic Rhinitis. Otolaryngol. Head Neck Surgery 2015, 152(1 supl.): 1-43.
14. Samoliński B., Rapiejko P., Lipiec A., Kurzawa R.: Metody ograniczania narażenia na alergen. W: Kruszewski J., Kowalski M.L. (red.): Standardy w alergologii. Część I. Medycyna Praktyczna, Kraków 2010: 145-149.